從現有市場藥品之代謝物發展新型NMDA 受體調節劑---(子計畫二)合成與設計新型NMDA 受體調控劑治療精神分裂相關疾病

Full metadata record

DC Field	Value	Language
dc.contributor.author	孫仲銘	en_US
dc.contributor.author	SUN CHUNG-MING	en_US
dc.date.accessioned	2014-12-13T10:52:01Z	-
dc.date.available	2014-12-13T10:52:01Z	-
dc.date.issued	2014	en_US
dc.identifier.govdoc	MOST103-2325-B009-001	zh_TW
dc.identifier.uri	http://hdl.handle.net/11536/103048	-
dc.identifier.uri	https://www.grb.gov.tw/search/planDetail?id=8385544&docId=450094	en_US
dc.description.sponsorship	科技部	zh_TW
dc.language.iso	zh_TW	en_US
dc.title	從現有市場藥品之代謝物發展新型NMDA 受體調節劑---(子計畫二)合成與設計新型NMDA 受體調控劑治療精神分裂相關疾病	zh_TW
dc.title	Discovery and Synthesis of Novel N-Methyl D-Asperate (Nmda) Receptor Modulator for Their Therapeutic Utility in Schizophrenia	en_US
dc.type	Plan	en_US
dc.contributor.department	國立交通大學應用化學系（所）	zh_TW
Appears in Collections:	Research Plans